Boğaziçi CT3
Boğaziçi CT Joint Event #9
About the talk: "Nanoparticle-biomolecule interactions: The next horizon for antibiotics"
Innovative Initiatives in the Health Industry Cluster
At the event organized in collaboration with the ISO 31st Professional Committee for the Pharmaceutical, Medical Device and Equipment Industry and İSEK, discussions focused on innovation and entrepreneurship in the health sector, public support mechanisms, commercialization, and opportunities for inter-institutional collaboration.
“From Molecule to Drug” Research Summer School ’26
Hosted by Boğaziçi University and CT³, the “From Molecule to Drug” Research Summer School 2026 was held on 6–10 July 2026 to promote an interdisciplinary approach to drug research.
Boğaziçi CT³ Open Events #7
As part of the Boğaziçi CT³ Open Events series, this seminar explored current approaches in personalized drug development and perspectives on global collaboration.
Laboratory Animal Use Course
Organized in collaboration with Boğaziçi University and CT³, the Laboratory Animal Use Course was held at Boğaziçi University’s Kandilli Campus from 1 to 12 June 2026.
Boğaziçi CT³ Open Events #6
In the sixth session of the Boğaziçi CT³ Open Events series, innovative approaches in translational biotechnology were discussed from an interdisciplinary perspective.
TÜSEB Visit
A TÜSEB delegation, including Batuhan Yeşilyurt, Assoc. Prof. Dr. Zeliha Özdemir Köken, and Assoc. Prof. Dr. Aziz Küçük, toured our infrastructure units and received comprehensive information on our center’s capabilities and development vision in targeted therapy technologies.
Expomed 2026
Boğaziçi CT³ took part in the Innovation Area at Expomed Eurasia 2026, presenting its research-to-product infrastructure and collaboration opportunities. During the event, the center met with more than 50 companies to explore potential partnerships across academia, industry, and entrepreneurship.
Phase 1 Success for Türkiye’s First Original Drug Candidate from the CT³ Ecosystem
The successful completion of the Phase 1 clinical trial of RS-0139, Türkiye’s first original drug candidate developed by RS Research, has provided a tangible demonstration of CT³’s translational R&D capacity spanning fundamental science through to product development.
“From Molecule to Drug” Research Winter School 2026
Organized by Boğaziçi CT³, the “From Molecule to Drug” Research Winter School 2026 was delivered as an intensive five-day science programme for high school students interested in the natural sciences and passionate about research.
Global Fellowship Opportunity at Boğaziçi University CT³ – CoCirculation3 Program
Boğaziçi CT³ is a multidisciplinary innovation hub dedicated to developing personalized, targeted, and advanced therapeutic technologies. Our research spans fundamental science, translational medicine, and clinical application, bridging academia, healthcare, and industry.
Advanced Training Focused on Clinical and Animal Research
An advanced training programme was delivered on cell and exosome applications in plastic surgery, addressing clinical practice, experimental clinical studies, and animal models alongside project development and scientific publication processes.
Boğaziçi University CT³ Receives OECD Good Laboratory Practice (GLP) Compliance Certification!
This recognition has further strengthened our commitment to reliability, traceability, and international compliance, while providing important momentum to our ecosystem’s R&D capacity in bringing next-generation health solutions closer to clinical application.
“From Molecule to Drug” Research Summer School
The “From Molecule to Drug” Research Summer School, organized by the Boğaziçi University Center for Targeted Therapy Technologies, was specially designed and delivered for science-oriented high school students with a strong interest in research.
Visit by Šekib Umihanić
At the Boğaziçi University Center for Targeted Therapy Technologies (CT³), we welcomed Prof. Dr. Šekib Umihanić, Director of the University Clinical Center Tuzla (UKC Tuzla), and shared information on our ongoing R&D activities and infrastructure capabilities.
Visit by Asım Hocaoğlu
Dr. Asım Hocaoğlu, General Manager of Kızılay Biomedical, and his team visited our center, where potential collaborations in the field of targeted therapy technologies were discussed.
Boğaziçi CT³ Open Events #1
At an event hosted by the In-Body Device Technologies Platform, medical device development and commercialization processes were explored from a broad perspective covering risk management, quality systems, technology readiness levels, and academia–industry collaboration.
3rd Targeted Therapy Technologies Symposium
Boğaziçi CT³ organized the third edition of its annual symposium series to share current developments in targeted therapy technologies, strengthen research collaborations, and develop shared scientific roadmaps.
In Memory of Prof. Dr. Banu Onaral
Prof. Dr. Banu Onaral, a Boğaziçi University alumna renowned for her pioneering contributions to science and her visionary, people-centered approach, was commemorated at a special event held on 18 January 2025.
2Tech Meetings
The November 2024 session of the 2Tech Meetings series, organized by the Boğaziçi University Center for Targeted Therapy Technologies (CT³), addressed ageing and quality of life in later years from the perspective of technological transformation, highlighting key societal and healthcare challenges in this field.
2Tech Meetings
The October session of the 2Tech Meetings series, organized by the Boğaziçi University Center for Targeted Therapy Technologies (CT³), focused on Precision Oncology, an increasingly important area in cancer research and clinical practice.
We Are at BioExpo 2024!
Throughout the exhibition, visitors to the Boğaziçi University stand had the opportunity to learn about the research activities that had recently gained momentum at our center, as well as our infrastructure capabilities.
Boğaziçi LifeSci Symposium II
The symposium was organized within the scope of the “R&D Support Laboratories Project for Increasing the Global Competitiveness of Life Sciences SMEs,” implemented under the Competitive Sectors Programme.
Boğaziçi LifeSci Symposium
The symposium was organized within the scope of the “R&D Support Laboratories Project for Increasing the Global Competitiveness of Life Sciences SMEs,” implemented under the Competitive Sectors Programme.